Cholinergics- Muscarinics Flashcards
Cholinergics
Agents that bind nicotinic and/or muscarinic receptors and mimic effects of ACh, can be both excitatory and inhibitory
Giving exogenous ACh
M3 release endothelial nitric oxide to vasodilate, M2 reduce heart rate
Atropine with cholinergics
Blocks muscarinic receptors, ACh can only bind to nicotinic receptors, release of NE, NE acts on alpha-receptors to vasoconstrict
Direct-acting muscarinic cholinergics
Agonists- Cholinomimetics
Antagonists- Antimuscarinics
Direct-acting nicontinic cholinergics
Agonists- Cholinomimetics
Antagonists
Indirect-acting cholinomimetics
Choline esterase inhibitors (ChEI)
Muscarinics
Compounds that selectively bind and activate/inactivate muscarinic receptors, actions similar to alkaloid muscarine
Muscarinic actions
Correpond to parasympathetic stimulation through release of ACh at parasympathetic postganglionic sites
Exceptions to muscarinic actions
ACh vasodilate blood vessels but no parasympathetic innervation to blood vessels, ACh released at sweat glands by sympathetic innervation
Muscarinic receptors
G-protein coupled receptors, Gq, Gi, G0
Gq activation
Activated by M1, M3, M5
Gi activation
Activated by M2, M4
Action of G0
Increases opening probability of G-protein modified inwardly rectifying K channels, mediated by M2, M4, hyperpolarizes the cell, metabotropic
Alkaloids
Natural compounds, muscarine, pilocarpine
Muscarine
No clinical use, found in certain mushrooms, used as investigational tool to differentiate between agents with muscarinic or nicotinic activity
Pilocarpine
Tertiary cholinomimetic alkaloid, well absorbed, partial agonist
Choline esters
Agents with modified ACh structure for more muscarinic receptor selectivity and less susceptibility to cholinesterase inactivation, charged, little CNS penetration
Methyl group of choline esters
Makes drug more selective for muscarinic receptors
Acetyl to carbamol substitution on choline esters
Confers resistance to cholinesterase hydrolysis
Muscarinic effects on eye
Muscarinic agonists contract both iris sphincters and ciliary muscles through M3, iris pulled away from anterior chamber, trabecular meshwork at base of ciliary muscle opened, both facilitate aqueous humor outflow into canal of Schlemm
Cardiovascular effects of muscarinics
M2 mediates an increase in K current in cardiac cells to cause hyperpolarization, reduce action potential duration, decrease contractility of the heart
Cardiovascular effects of low concentrations of muscarinics
Activation of M3 on endothelial cells release NO, diffuses to adjacent vascular smooth muscle to activate guanylyl cyclase, increase cGMP, causes vasodilation, will stimulate reflex to return blood pressure to normal
Cardiovascular effects of high concentrations of muscarinics
Activation of M3 on vascular smooth muscle stimulates IP3 production, releases intracellular calcium, causes vasoconstriction
Muscarinic effects on lungs
M3, contraction of bronchial muscle (bronchoconstriction), stimulation of bronchial glands
Muscarinic effects on GI
M3, increase motility, relax sphincters, stimulates secretion
Muscarinic effects on bladder
M2, M3, contraction of detrusor, relaxation of trigone and sphincter
Muscarinic effects on glands
M3, stimulates sweat, salivary, lacrimal, nasopharyngeal secretion
Muscarinic effects in CNS
M1 expressed in areas involving cognition, M2 mediates tremor, hypothermia, antincociception, M3 in hypothalamus, reduces appetitie and dimishes body fat mass
Clinical uses of acetylcholine
Direct-acting choline ester, miosis induction for eye surgery
Clinical uses of metacholine
Direct-acting choline ester, asthma diagnosis
Clinical uses of carbachol
Direct-acting choline ester, miosis induction for eye surgery, glaucoma
Clinical uses of bethanechol
Direct-acting choline ester, urinary retention, agent of choice for post-op, postpartum, and drug-related urinary retention, used to increase tone of the lower esophageal sphincter in patients with reflux esophagitis
Clinical uses of pilocarpine
Direct-acting alkaloid, glaucoma, Sjogren’s syndrome (xerostomia)- systemic autoimmune disease where immune cells destroy exocrine glands
Clinical uses of cevimeline
Direct-acting muscarinic agonist for treatment of dry mouth associated with Sjogren’s syndrome
Side effects of muscarinics
Diarrhea, urination, miosis/muscle weakness, bronchospasm, bradycardia, excitation, lacrimation, salivation/sweating/seizures (DUMBBELS)
Contraindications of muscarinics
Coronary insufficiency (reduced blood pressure exacerbates decrease in coronary blood flow), hyperthyroidism (reduces AV conduction with increased heart rate- arrhythmia), asthma (bronchoconstriction), peptic ulcer disease (increased gastric acid secretion)
Muscarinic antagonists
Sometimes called parasympatholytics- do not lyse parasympathetic neurons, exert effects not predictable from block of parasympathetic nervous system, better called antimuscarinics
Classes of muscarinic antagonists
Naturally occuring alkaloids- atropine, scopolamine
Semisynthetic derivatives of alkaloids- ipratropium, tiotropium
Synthetic congeners with selectivity for muscarinic receptor subtypes- tolterodine
Atropine
Alkaloid, used to dilate pupils
Scopolamine
Alkaloid, used for prophylactic treatment of motion sickness
Ipratropium, tiotropium
Quaternary compounds, do not cross the blood brain barrier, used for bronchial asthma and COPD
Tolterodine
Treatment of urinary incontinence
Pharmacokinetics of alkaloid and tertiary antimuscarinic
Well absorbed from the gut and conjunctival membranes, can get into CNS, scopolamine is rapidly distributed into the CNS, has greater effects than other antimuscarinics
Pharmacokinetics of quaternary antimuscarinics
Only 10-30% of the drug is absorbed and are poorly taken up by the brain, less CNS effect, exhibit greater nicotinic blocking activity and more likely to interfere with ganglionic or neuromuscular transmission
Pharmacodynamics of atropine
Reversible inhibitor of muscarinic receptors, receptors are active, most drugs that block actions of ACh are inverse agonists, atropine binds nicotinic receptors with low potency
CNS effects of scopolamine
Low doses- produces CNS depression, drowsiness, amnesia
High doses- can cause excitement, agitation, hallucinations, delirium, coma
CNS effects of atropine
Low doses- causes mild vagal excitement
High doses- can cause excitement, agitation, hallucinations, delirium, coma
Effects of antimuscarinics on the eye
Cause unopposed sympathetic dilator activity and mydraisis, Weaken contraction of ciliary muscle, cycloplegia, which results in loss of accomodation and focus for near vision, may cause acute glaucoma
Effects of antimuscarinics in the heart
Low doses- reduction in heart rate due to blockade of presynaptic M1 receptors (normally limit ACh release)
High dose- tachycardia
Respiratory effects of antimuscarinics
Can cause bronchodilation and reduce secretion, not useful in asthma treatment, limited effectiveness in COPD due to blockade of parasympathetic postganglionic presynaptic M2 autoreceptors, frequently used before inhalant anesthetics to reduce secretions
GI effects of antimuscarinics
Impaired tone and motility, prolonged gastric emptying time, induced intestinal paralysis is temporary
Effects of antimuscarinics on urinary tract
Relaxes smooth muscle of ureters and bladder and slows voiding, may precipitate urinary retention in men with prostatic hyperplasia
Effects of antimuscarinics on glands
Inhibit secretion of most glands, leading to dry mouth and dry skin
Clinical uses of antimuscarinics
Inhibit effects of parasympathetic nervous system activity, have undesired side effects that are usually not serious, local administration to minimize systemic absorption
Side effects of 0.5 mg atropine
Depress salivary and bronchial secretion and sweating
Side effects of 1 mg atropine
Pupils dilate, accomodation of lens to near vision inhibited, vagal effects on heart are blocked (increases heart rate)
Side effects of 2 mg atropine
Inhibit parasympathetic control of urinary bladder and GI tract, inhibit micturition and decrease tone and motility of the gut
Side effects of 5 mg atropine
Gastric secretion and motility inhibited
Side effects of >10 mg atropine
Excitement, hallucination, delirium, coma
Contraindications of antimuscarinics
Patients with glaucoma, elderly men (increased incidence for prostatic hyperplasia), increase symptoms in patients with gastric ulcer